BioLineRx Ltd
BLRX
|
|
|
|
Trading Volume | 1,018,187 |
|
2.45 - 0.56 |
Market Cap Full | $ 618.4M |
Quarterly +
2025 | 2024 | 2023 | 2022 | |
---|---|---|---|---|
Q1 | 26.5% | -29.3% | 48.8% | -15.4% |
Q2 | - | -33.1% | 81.7% | -25.2% |
Q3 | - | -15.2% | 14.1% | -27.3% |
Q4 | - | -14.9% | -10.8% | -36.6% |
Monthly +
J | F | M | A | M | J | J | A | S | O | N | D |
2025 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
26.5 | - | - | - | - | - | - | - | - | - | - | - |
2024 | |||||||||||
-24.2 | 11.8 | -16.5 | -41.4 | 14 | -22 | 36.7 | -15.2 | - | - | - | - |
2023 | |||||||||||
6.8 | -4.8 | 46.3 | 21.9 | 47.2 | 1.3 | -3.5 | 13.6 | 4 | -17.6 | -3.3 | 8.3 |
2022 | |||||||||||
-11.4 | -13.4 | 10.3 | -28.7 | 27.9 | -18 | 3.1 | 15.2 | -38.8 | -8.6 | -17.7 | -15.7 |
2021 | |||||||||||
13.1 | 8.4 | -9.7 | 12.5 | -8.9 | -1.8 | 15 | -11.2 | -5.6 | 4.8 | -7.4 | -23.2 |
2020 | |||||||||||
3.9 | -23.3 | -27.7 | 26.3 | 15.5 | -11.9 | 32.8 | -15.4 | -14.6 | 20.7 | 15.7 | 10 |
EPS
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Q1 | -0.2 | -0.2 | -0.3 | -0.6 |
Q2 | -0.3 | -0.2 | -0.2 | -0.5 |
Q3 | -0.3 | -0.2 | -0.2 | -0.3 |
Q4 | 0 | 0 | 0 | -0.5 |
A | -0.75 | -0.45 | -0.6 | -1.8 |